Similar articles for PMID: 16082428

Year	Number of Results
2001	1
2002	8
2003	12
2004	19
2005	26
2006	22
2007	21
2008	15
2009	13
2010	16
2011	27
2012	25
2013	18
2014	12
2015	12
2016	7
2017	10
2018	7
2019	4
2020	5
2021	3
2022	5
2023	3
2024	0

1

Preclinical and clinical development of the proteasome inhibitor bortezomib in cancer treatment.

Montagut C, Rovira A, Mellado B, Gascon P, Ross JS, Albanell J. Montagut C, et al. Drugs Today (Barc). 2005 May;41(5):299-315. doi: 10.1358/dot.2005.41.5.893706. Drugs Today (Barc). 2005. PMID: 16082428 Review.

2

The proteasome: a novel target for anticancer therapy.

Montagut C, Rovira A, Albanell J. Montagut C, et al. Clin Transl Oncol. 2006 May;8(5):313-7. doi: 10.1007/s12094-006-0176-8. Clin Transl Oncol. 2006. PMID: 16760005 Review.

3

Proteasome inhibition and its clinical prospects in the treatment of hematologic and solid malignancies.

Ludwig H, Khayat D, Giaccone G, Facon T. Ludwig H, et al. Cancer. 2005 Nov 1;104(9):1794-807. doi: 10.1002/cncr.21414. Cancer. 2005. PMID: 16178003 Free article. Review.

4

Discovery, Development, and clinical applications of bortezomib.

Jung L, Holle L, Dalton WS. Jung L, et al. Oncology (Williston Park). 2004 Dec;18(14 Suppl 11):4-13. Oncology (Williston Park). 2004. PMID: 15688597 Free article. Review.

5

Bortezomib: proteasome inhibition as an effective anticancer therapy.

Richardson PG, Mitsiades C. Richardson PG, et al. Future Oncol. 2005 Apr;1(2):161-71. doi: 10.1517/14796694.1.2.161. Future Oncol. 2005. PMID: 16555986 Review.

6

Proteasome inhibition in the treatment of cancer.

Richardson PG, Mitsiades C, Hideshima T, Anderson KC. Richardson PG, et al. Cell Cycle. 2005 Feb;4(2):290-6. Epub 2005 Feb 3. Cell Cycle. 2005. PMID: 15655370 Review.

7

[Proteasome inhibitor].

Yamamura M, Hirai T, Yamaguchi Y. Yamamura M, et al. Nihon Rinsho. 2010 Jun;68(6):1079-84. Nihon Rinsho. 2010. PMID: 20535959 Review. Japanese.

8

Bortezomib as the first proteasome inhibitor anticancer drug: current status and future perspectives.

Chen D, Frezza M, Schmitt S, Kanwar J, Dou QP. Chen D, et al. Curr Cancer Drug Targets. 2011 Mar;11(3):239-53. doi: 10.2174/156800911794519752. Curr Cancer Drug Targets. 2011. PMID: 21247388 Free PMC article. Review.

9

Proteasome: an emerging target for cancer therapy.

Zavrski I, Jakob C, Schmid P, Krebbel H, Kaiser M, Fleissner C, Rosche M, Possinger K, Sezer O. Zavrski I, et al. Anticancer Drugs. 2005 Jun;16(5):475-81. doi: 10.1097/00001813-200506000-00002. Anticancer Drugs. 2005. PMID: 15846112 Review.

10

Proteasome inhibition: a new approach for the treatment of malignancies.

Spano JP, Bay JO, Blay JY, Rixe O. Spano JP, et al. Bull Cancer. 2005 Nov;92(11):E61-6, 945-52. Bull Cancer. 2005. PMID: 16316823 Free article. Review. English, French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

270 results

Results by year